Wednesday, December 26, 2012

Purine metabolites in fibromyalgia syndrome.

Purine metabolites in fibromyalgia syndrome.
http://www.ncbi.nlm.nih.gov/pubmed/23000315
 
Fais A, Cacace E, Corda M, Era B, Peri M, Utzeri S, Ruggiero V.
Clin Biochem. 2012 Sep 18. pii: S0009-9120(12)00539-5. doi: 10.1016/j.clinbiochem.2012.09.009. [Epub ahead of print]

Source
Dipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, 09042 Monserrato, Cagliari, Italy.
Abstract
OBJECTIVE:
To evaluate serum purine metabolite concentrations in patients affected by fibromyalgia syndrome (FMS) and the relationships between their levels and FM clinical parameters.
DESIGN AND METHODS:
Serum purine levels were quantified using LC/UV-vis in 22 fibromyalgic females (according to the American College of Rheumatology classification criteria) and 22 healthy females.
RESULTS:
Significantly higher serum inosine, hypoxanthine and xanthine levels (p<0.001) and significantly lower serum adenosine (p<0.05) were detected in the FMS patients vs healthy controls. Our data show a negative correlation between adenosine and Fibromyalgia Impact Questionnaire (FIQ).
CONCLUSIONS:
Study results suggest that purines, in particular adenosine and inosine, may be involved in pain transmission in fibromyalgia.

PMID: 23000315 [PubMed - as supplied by publisher]

Blog Archive